Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Diastereomeric Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthesis of optically active 1-amino-2-vinylcyclopropane carboxylic acid esters via chiral resolution. Reliable pharmaceutical intermediate supplier offering cost-effective antiviral API precursors.
Patent CN101289417B details an advanced purification process for D-3-thioacetyl-2-methylpropionyl-L-proline, offering superior yield and optical purity for captopril manufacturing.
Patent CN113429328A details a low-cost tartaric acid resolution method for chiral fluorinated pyrrolidines, enabling scalable API intermediate production.
Patent CN1989093A details a scalable diastereomeric resolution method for spirobiindane derivatives, offering cost reduction and high purity for liquid crystal and polymer applications.
Advanced synthesis of chiral tetrahydroquinoline derivatives via diastereomeric resolution. Reliable supplier for scalable API intermediates with optimized cost structures.
Advanced resolution process for IRS drug intermediates via diastereomeric salt crystallization. Enhances purity and reduces manufacturing costs for pharmaceutical supply chains.
Patent CN115197115B reveals novel chiral synthesis. Enables cost reduction and high purity for pharmaceutical intermediates manufacturing supply chains.
Solve low-yield and low-purity issues in trans-2-aminocyclohexanol production. This patent's 2-methoxyphenylacetic acid resolution method achieves >99%ee and 67% yield, reducing costs for pharma intermediates.